lindas have a posse
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Landmark Trial Results speak for itself.
Supplements do not have any impact on Glioblastoma. Your conclusions are nonsense.
Astounding.
Can you imagine billions in sales coming your way? That's the rational conclusion of our management's emphasis on global manufacturing as well as allowing Landmark Trial Data to mature to the point that it can be understood by contemporary regulators.
It's really quite amazing that we have this sellar revolutionary trial data that shows benefit for GBM patients but also reveals how clinicial trials can be conducted in a more humane way.
There's many scientific, business, and philosophical reasons to own stock in Northwest Biotherapeutics.
If you think there's no news for the rest of 2023 then it sounds like you shouldn't own this stock.
Speak for yourself
Management own more shares than all posters on this forum combined.
If you want management to work for free then start your own nonprofit. Take no salary or any compensation. Set an example for all of us.
A lot happened since 2020 yet you simply ignore all of those achievements.
Naked shorting happens all day every day.
Management own more shares than all posters on this forum combined. If they don't care about the stock price that's an obvious signal of future appreciation otherwise they would be selling like Novocure insiders.
Correct, none of the compassionate use patients are paying for years of doses upfront. So in reality the facility could be treating a half dozen or more each month.
Responding to delisting notification with a reverse split.
That's correct hoffman. In their 2023 goals PR they said MHRA submission and beginning of the pediatric trial.
The pediatric trial can begin once MHRA accepts the application. It does not have to wait until MHRA approval for DCVax. Obviously that's because MHRA are basically guaranteed to approve DCVax once they accept the application.
I agree ATL. We have some very nefarious immoral forces seeking fo bankrupt Northwest Biotherapeutics.
$58.60!
Well said Gary. We are moving forward every day!
As Linda said at the 2022 ASM, and many times previously, BP isn't well aligned to develop a novel autologous personalized cancer vaccine.
If you are so unhappy you have a solution.
Sell your shares.
Linda left Enron in 1997 before anyone knew of the fraud. She probably did. A visionary.
She left around 1997.
Along with half of Houston Texas.
Linda Powers wrote NAFTA, EU Patent Law, and taught at Georgetown.
I agree
Multiple resections are futile without DCVax. Surgery alone does nothing for Glioblastoma.
Management are working 24/7 on approval. That's all that matters.
They will be at $5 post DCVax approval.
I agree supernovae imminent.
"DCVax or Death" should be on the next tote bag.
It screams wash trading, spoofing, and longs who are already overweight on the stock not selling!
Move your money then buy.
Landmark Trial Results
Thermo manages a huge portfolio. He probably isn't worried about NWBO nor obsessed with it daily.
My mamma said ain't ain't a word.
Landmark Trial Results!
JAMA!
MHRA Trial Endorsement (PIP)!
MHRA-endorsed Manufacturing (MIA)!
Global Patent Protection!
My nearly 6000K shares should be worth $40M or more once Northwest Biotherapeutics obtains global approval on nGBM and rGBM indications.
I see no reason to sell my shares since I can borrow against them once NWBO are off OTC.
In my personal opinion as a retail investor representing myself alone, and not providing investment advice, longs must focus upon the deep value present in Northwest Biotherapeutics stock!
The astute Robert Hefner agrees:
Dr. Ashkan is the genius behind this viral vid of him performing brain surgery while his patient was awakened to play the violin…mid-surgery. He told me he champions DCVax-L bc of trial data along with what he’s seen first-hand from his patients. $NWBOhttps://t.co/XFTeSPFtH5
— Wade Kovash (@wkovash) June 6, 2022
Watch one of the world’s preeminent neurosurgeons explain the significance of $NWBO ‘s Phase III trial of DCVax-L. The results are groundbreaking and represent an enormous advancement in one of the most tragic cancers. https://t.co/eQw5tAsivK
— Wade Kovash (@wkovash) June 6, 2022
From suck to blow!
I agree LP will be on Time Magazine.
I would rather see perp walks. There's a lot of money available without having those people as investors.
Hours before presenting Landmark Trial Data the Mafia cabal, figureheaded by obese edgelord Adam Feuerstein, began manipulation of NWBO stock. Had that not occurred we could be at $10 today. Management know they need to get off OTC. So in my opinion they're keeping their power dry until that one big day we hear about MHRA approval.
NICE allows up to 100K per QALY for orphan and rare diseases. They will certainly reimburse DCVax.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169141878
NWBO hold technology which could lead to the first trillion dollar biotechnology market capitalization. You can criticize my prediction all you want but that doesn't invalidate the market disrupting potential of DCVax.
Your attempts to consistently throw cold water on what should be a hot celebratory party after the Mechanism of Action talk at ASCO 2023 seems very telling.
I don't know why a shareholder would devote so much time towards trashing this great company, their life-saving technology, or the management team which delivered Landmark Trial Results.
I agree bio.